- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07630324
MEG and Aphantasia (MEGAPHANTASIA)
Cerebral Oscillations During Covert Actions in Aphantasia
Covert actions are cognitive processes that involves the motor system. They include motor imagery, movement preparation, action observation or action language. They imply mental simulations, based on activations of neural networks, involved in specific operations such as perceiving or acting. These mental phenomena have intrigued and still intrigue philosophers, psychologists, and neuroscientists, as they are complex and introspective processes, which play a major role in human cognition.
To decipher similarities and differences between these types of covert actions, the investigators will focus on persons living with aphantasia, which is a neurocognitive specificity present in a small proportion of the population (5 to 8%). Aphantasia is characterized by the alteration or the absence of explicit mental representations.
This population offers an ideal testbed to disentangle the involvement of cognitive and motor processes in different forms of covert actions.
By means of magnetoencephalography, this study aims to identify and compare brain patterns and their temporal dynamics in alpha and beta bands during covert actions in two groups of healthy volunteers: aphantasics and non-aphantasics (i.e., having a non-altered imagery capacity).
If covert actions indeed share brain networks, the investigators expect aphantasics to present reduced neural and behavioral activation during the explicit (i.e., motor imagery) and implicit (movement preparation, action language and action observation) forms of covert actions.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Florent LEBON, PhD
- Phone Number: +336 450 445 26
- Email: florent.lebon@univ-lyon1.fr
Study Locations
-
-
-
Bron, France
- CERMEP
-
Contact:
- Yves ROSSETTI, Professor
- Phone Number: +334.78.86.50.21
- Email: yves.rossetti@inserm.fr
-
Principal Investigator:
- Yves ROSSETTI, Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18 to 60 years
- Willing to actively participate in the study
- Having signed an informed consent form to participate in the study
Inclusion Failure Criteria:
Identification of individuals with and without aphantasia based on responses to a questionnaire validated in the literature: Vividness of Movement Imagery Questionnaire, second version (VMIQ-2):
Scores required for inclusion in the aphantasic group
- VMIQ-2: internal visual imagery score = 55-60
- VMIQ-2: kinesthetic imagery score = 55-60
Scores required for inclusion in the non-aphantasic group
- VMIQ-2: internal visual imagery score = 20-36
- VMIQ-2: kinesthetic imagery score = 20-36
Exclusion Criteria:
- Neurological or psychiatric disorders
- History of neurological or psychiatric disorders
- Sleep disorders that may affect data variability or quality, or participant cooperation and retention, as assessed by the principal investigator or co-investigator during the inclusion interview
- Volunteers presenting standard contraindications to MEG and MRI examinations:
- Presence of incompatible metal in the body (pacemaker, implanted pump including insulin pump, neurostimulator, cochlear implants or other hearing devices, metallic prosthesis, intracerebral/surgical aneurysm clips, implantable defibrillator, ferromagnetic foreign bodies in the eyes or brain in the upper body, ventriculoperitoneal shunt valves, dental braces or steel posts in root canals, ferromagnetic foreign bodies in the upper body)
- Claustrophobia
- Pregnant or breastfeeding women
- Individuals under guardianship, curatorship, or legal protection
- Individuals deprived of liberty
- Individuals undergoing psychiatric care
- Individuals admitted to a health or social institution for reasons other than clinical research
- Individuals not affiliated with a social security system or not beneficiaries of such a system
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aphantasics
Healthy individuals with altered mental imagery (score between 55 and 60 for each modality at the vividness of motor imagery questionnaire - second version)
|
Within a single session, measure of brain oscillations during four types of covert actions (motor imagery, action observation, action language and movement preparation).
Anatomical MRI, performed once
Before MEG and MRI, measure of vividness for internal visual imagery, external visual imagery and kinesthetic imagery (for 12 actions).
|
|
Active Comparator: Non-aphantasics
Healthy individuals with non-altered mental imagery (score between 20 and 36 for each modality at the vividness of motor imagery questionnaire - second version)
|
Within a single session, measure of brain oscillations during four types of covert actions (motor imagery, action observation, action language and movement preparation).
Anatomical MRI, performed once
Before MEG and MRI, measure of vividness for internal visual imagery, external visual imagery and kinesthetic imagery (for 12 actions).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Whole-brain power of beta band (Tesla2)
Time Frame: During MEG recording
|
Power of beta band with whole brain analysis during each of the four covert actions (motor imagery, action observation, movement preparation and action language).
|
During MEG recording
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Whole-brain power of alpha band (Tesla2)
Time Frame: During MEG recording
|
Power of alpha band with whole brain analysis during each of the four covert actions (motor imagery, action observation, movement preparation and action language).
|
During MEG recording
|
|
Power of beta band (Tesla2) in the primary motor cortex
Time Frame: During MEG recording
|
Power of beta band in M1 during each of the four covert actions (motor imagery, action observation, movement preparation and action language).
|
During MEG recording
|
|
Power of alpha band (Tesla2) in the primary motor cortex
Time Frame: During MEG recording
|
Power of alpha band in M1 during each of the four covert actions (motor imagery, action observation, movement preparation and action language).
|
During MEG recording
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yves ROSSETTI, Professor, Hospices Civils de Lyon
- Study Director: Florent LEBON, PhD, Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM UR7424)
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 69HCL26_0176
- 2026-A01303-48 (Other Identifier: ID-RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MEG
-
Hospices Civils de LyonMAG4HealthNot yet recruiting
-
National Institute of Mental Health (NIMH)RecruitingNormal PhysiologyUnited States
-
Hospices Civils de LyonNot yet recruitingPatients Diagnosed With a Malignant GliomaFrance
-
National Institute of Neurological Disorders and...Recruiting
-
University of ArkansasCompletedEpilepsyUnited States
-
Hospices Civils de LyonNot yet recruitingNormal Subject | Patient With Pharmaco-resistant EpilepsyFrance
-
Shalvata Mental Health CenterBar-Ilan University, IsraelUnknownSchizophrenic PatientsIsrael
-
Hospices Civils de LyonRecruitingEpilepsy | Drug-resistant Epilepsy | Candidates for Surgical TreatmentFrance
-
University Hospital, GrenobleTerminatedCerebral Primitive Tumor With Chirurgical IndicationFrance
-
National Institute of Neurological Disorders and...Recruiting